AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Dutasteride; Tamsulosin Hydrochloride in Nigeria
7 products registered with NAFDAC — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Tamsulosin Hydrochloride and Dutasteride Capsules_ Capsule | A4-101616 | Embassy Pharmaceutical and Chemicals Limited | active | 28 Oct 2030 |
| Tamduster Tablets_ Tablet | B4-9441 | Activity Pharmaceutical Co. Ltd | active | 30 Oct 2029 |
| Tamsudart Capsules Capsule | B4-7876 | Eldoxa Ltd | active | 30 Jan 2029 |
| Flowel Plus Capsules Capsule | B4-9016 | Superior Pharmaceuticals Limited | active | 30 Aug 2028 |
| Co-Strimax Tablet | A4-100392 | Evans Therapeutics Limited | active | 24 May 2028 |
| Duostam Tablets** Tablet | C4-1573 | Pharmacy Plus Ltd | active | 24 Feb 2026 |
| Duodart Capsules** Capsule | B4-3532 | GlaxoSmithKline Consumer Nigeria PLC (GSK) | active | 9 Nov 2025 |
Dutasteride; Tamsulosin Hydrochloride — NAFDAC Registration Details
NAFDAC (Nigeria) has 7 registered products containing Dutasteride; Tamsulosin Hydrochloride, of which 7 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Dutasteride; Tamsulosin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.